Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Knuth

Showing results (181-190 of 189) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 189 results.
Arthritis and Rheumatism|December 30, 2009
Functional autoantibodies against serpin E2 in rheumatoid arthritisH Maciejewska-Rodrigues, M Al-Shamisi, H Hemmatazad, et al.
European Journal of Cancer (Oxford, England : 1990)|May 30, 2001
A pilot study of whole body hyperthermia and carboplatin in platinum-resistant ovarian cancerA M Westermann, E A Grosen, D M Katschinski, et al.
British Journal of Cancer|August 28, 2015
Brain metastases in gastro-oesophageal adenocarcinoma: insights into the role of the human epidermal growth factor receptor 2 (HER2)J Feilchenfeldt, Z Varga, M Siano, et al.
Oncology|May 22, 2003
A Systemic Hyperthermia Oncologic Working Group trial. Ifosfamide, carboplatin, and etoposide combined with 41.8 degrees C whole-body hyperthermia for metastatic soft tissue sarcomaA M Westermann, G J Wiedemann, E Jager, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 23, 2000
Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III studyH von der Maase, S W Hansen, J T Roberts, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 7, 2023
Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III StudyH von der Maase, S W Hansen, J T Roberts, et al.
Frontiers in Psychology|December 6, 2021
Building a Networked Improvement Community: Lessons in Organizing to Promote Diversity, Equity, and Inclusion in Science, Technology, Engineering, and MathematicsChelsea E Noble, Marilyn J Amey, Luis A Colón, et al.
Der Urologe. Ausg. A|September 27, 2003
[Gemcitabine/cisplatin vs. MVAC. 5 year survival outcome of the phase III study of chemotherapy of advanced urothelial carcinoma in Germany]J Lehmann, M Retz, G Steiner, et al.
Geburtshilfe Und Frauenheilkunde|April 23, 2026
Fertility Preservation for Patients with Malignant Disease. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015/082, May 2025)Laura Lotz, Sabine Kliesch, Dunja Baston-Buest, et al.
Pageof 19

Showing results (181-190 of 189) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 189 results.
Arthritis and Rheumatism|December 30, 2009
Functional autoantibodies against serpin E2 in rheumatoid arthritisH Maciejewska-Rodrigues, M Al-Shamisi, H Hemmatazad, et al.
European Journal of Cancer (Oxford, England : 1990)|May 30, 2001
A pilot study of whole body hyperthermia and carboplatin in platinum-resistant ovarian cancerA M Westermann, E A Grosen, D M Katschinski, et al.
British Journal of Cancer|August 28, 2015
Brain metastases in gastro-oesophageal adenocarcinoma: insights into the role of the human epidermal growth factor receptor 2 (HER2)J Feilchenfeldt, Z Varga, M Siano, et al.
Oncology|May 22, 2003
A Systemic Hyperthermia Oncologic Working Group trial. Ifosfamide, carboplatin, and etoposide combined with 41.8 degrees C whole-body hyperthermia for metastatic soft tissue sarcomaA M Westermann, G J Wiedemann, E Jager, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 23, 2000
Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III studyH von der Maase, S W Hansen, J T Roberts, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 7, 2023
Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III StudyH von der Maase, S W Hansen, J T Roberts, et al.
Frontiers in Psychology|December 6, 2021
Building a Networked Improvement Community: Lessons in Organizing to Promote Diversity, Equity, and Inclusion in Science, Technology, Engineering, and MathematicsChelsea E Noble, Marilyn J Amey, Luis A Colón, et al.
Der Urologe. Ausg. A|September 27, 2003
[Gemcitabine/cisplatin vs. MVAC. 5 year survival outcome of the phase III study of chemotherapy of advanced urothelial carcinoma in Germany]J Lehmann, M Retz, G Steiner, et al.
Geburtshilfe Und Frauenheilkunde|April 23, 2026
Fertility Preservation for Patients with Malignant Disease. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015/082, May 2025)Laura Lotz, Sabine Kliesch, Dunja Baston-Buest, et al.
Pageof 19